(last SAB meeting in 2019)
The drug coming from the 503B grey vendor is a disaster waiting to happen, clinical Liability Nightmare for some wellness influencer to write a blog about
Basically, manipulating macros can then influence metabolic processes in the liver and other metabolic pathways
This stuff can get REALLY complicated, even beyond what I can dissect, but the short story is that when GLP-1 levels increase they activate circuitry in the brain that makes us want to eat less
Understanding the full potential of each molecule in improving both metabolic and mechanical obesity-related complications through research will support personalised pharmacotherapy choices
Future studies with specific outcomes, larger sample sizes, different ages, taking into consideration baseline glutathione levels, are needed to better assess treatment outcomes